Suppr超能文献

比较去甲肾上腺素联合晶体液与胶体液输注预防剖宫产脊麻低血压的剂量-反应研究。

Comparative Dose-Response Study on the Infusion of Norepinephrine Combined with Crystalloid Coload versus Colloid Coload for Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery.

机构信息

Department of Anesthesiology, Jinhua Maternity and Child Health Care Hospital, Jinhua, People's Republic of China.

Department of Anesthesiology, Wenling Maternity and Child Health Care Hospital, Taizhou, People's Republic of China.

出版信息

Drug Des Devel Ther. 2022 Aug 6;16:2617-2626. doi: 10.2147/DDDT.S378453. eCollection 2022.

Abstract

BACKGROUND

Although the optimal infusion dose of norepinephrine combined with crystalloid coload for preventing spinal anesthesia-induced hypotension (SAIH) for cesarean delivery has been established, the infusion regimen of norepinephrine combined with colloid coload has not been fully quantified. The objective of this study was to compare and determine the median effective dose (ED) and 90% effective dose (ED) of norepinephrine infusion combined with crystalloid coload versus colloid coload for preventing SAIH during cesarean delivery.

METHODS

Two hundred parturients were randomly assigned to receive norepinephrine infusion at 0.02, 0.04, 0.06, 0.08, or 0.10 µg/kg/min in combination with 10 mL/kg crystalloid coload or colloid coload to prevent SAIH. The study period was defined as the interval from the commencement of intrathecal injection to delivery of the neonate. The primary outcome was non-occurrence of hypotension, defined as systolic blood pressure (SBP) less than 80% of the baseline before delivery. The ED and ED of norepinephrine infusion dose were determined using probit regression analysis. By calculating the 95% confidence intervals (CIs) of relative median potency to determine whether the prophylactic infusion of norepinephrine requirement was different between the two groups.

RESULTS

The derived ED and ED of norepinephrine infusion combined with crystalloid coload were 0.030 (95% CIs 0.020 to 0.038) and 0.097 (95% CIs 0.072 to 0.157) µg/kg/min, respectively. The ED and ED of norepinephrine infusion combined with colloid coload were 0.021 (95% CIs 0.013 to 0.029) and 0.070 (95% CIs 0.053 to 0.107) µg/kg/min, respectively. The estimate of relative median potency for norepinephrine between the two groups was 1.37 (95% CIs 0.94 to 2.23).

CONCLUSION

Under the conditions of this study, 10 mL/kg colloid coload reduced the dose of prophylactic norepinephrine infusion by approximately 30% in parturients during spinal anesthesia for cesarean delivery compared with the crystalloid coload.

摘要

背景

尽管已经确定了去甲肾上腺素联合晶体液负荷预防止脊髓麻醉诱导的低血压(SAIH)用于剖宫产的最佳输注剂量,但去甲肾上腺素联合胶体液负荷的输注方案尚未完全量化。本研究的目的是比较并确定去甲肾上腺素联合晶体液负荷预防止剖宫产时 SAIH 的输注剂量中位数有效剂量(ED)和 90%有效剂量(ED)与胶体液负荷预防止剖宫产时 SAIH 的输注剂量。

方法

将 200 名产妇随机分为接受去甲肾上腺素输注 0.02、0.04、0.06、0.08 或 0.10 µg/kg/min 联合 10 mL/kg 晶体液负荷或胶体液负荷预防止 SAIH。研究期间定义为从鞘内注射开始到新生儿分娩的间隔。主要结局为无低血压发生,定义为收缩压(SBP)低于分娩前基线的 80%。采用概率单位回归分析确定去甲肾上腺素输注剂量的 ED 和 ED。通过计算相对中值效价的 95%置信区间(CI)来确定两组之间去甲肾上腺素预防性输注需求是否不同。

结果

去甲肾上腺素联合晶体液负荷的衍生 ED 和 ED 分别为 0.030(95%CI 0.020 至 0.038)和 0.097(95%CI 0.072 至 0.157)µg/kg/min。去甲肾上腺素联合胶体液负荷的 ED 和 ED 分别为 0.021(95%CI 0.013 至 0.029)和 0.070(95%CI 0.053 至 0.107)µg/kg/min。两组间去甲肾上腺素的相对中值效价估计值为 1.37(95%CI 0.94 至 2.23)。

结论

在本研究条件下,与晶体液负荷相比,剖宫产时脊髓麻醉中去甲肾上腺素预防性输注的剂量减少了约 30%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验